TMEM147 is a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma

Overview

Journal Genet Mol Biol

Specialty Genetics

Date 2023 Jun 19

PMID 37335919

Authors

Wen-Jie Fan

Meng-Xi Zhou

Di-Di Wang

Xin-Xin Jiang

Hao Ding

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is the most common type of liver malignancy with high incidence and poor prognosis. Transmembrane protein 147 (TMEM147) has been implicated in the development of colon cancer. However, the role of TMEM147 in HCC remains unclear. In this study, data of 371 HCC tissues, 50 adjacent nontumor tissues, and 110 normal liver tissues were retrieved from the TCGA and GTEx databases. TMEM147 expression was found to be increased in HCC tissues. High expression of TMEM147 was related to poor prognosis, and TMEM147 was confirmed to be an independent prognostic factor for HCC patients. A receiver operating characteristics (ROC) analysis was performed and showed that the diagnostic efficacy of TMEM147 was significantly higher than that of AFP (0.908 versus 0.746, p < 0.001). Furthermore, TMEM147 promoted tumor immune infiltration, and macrophages were the immune cells that predominantly expressed TMEM147 in HCC. Further analysis revealed that TMEM147 mainly impacted the ribosome pathway, and CTCF, MLLT1, TGIF2, ZNF146, and ZNF580 were predicted to be the upstream transcription factors for TMEM147 in HCC. These results suggest that TMEM147 serves as a promising biomarker for diagnosis and prognosis and may potentially become a therapeutic target for HCC.

Citing Articles

[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].

Mo Y, Zou Z, Chen E Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(6):715-725.

PMID: 39694527 PMC: 11726010. DOI: 10.3724/zdxbyxb-2024-0117.

Innovations in radiotherapy for tongue squamous cell carcinoma.

Hu S, Li X, Yang B, Yu T, Yi F, Qin X J Transl Med. 2024; 22(1):1082.

PMID: 39614244 PMC: 11605913. DOI: 10.1186/s12967-024-05885-2.

Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration.

Myers B, Brayer K, Paez-Beltran L, Villicana E, Keith M, Suzuki H Nat Commun. 2024; 15(1):10363.

PMID: 39609428 PMC: 11605073. DOI: 10.1038/s41467-024-54750-9.

SUMF1 overexpression promotes tumorous cell growth and migration and is correlated with the immune status of patients with glioma.

Zhang P, Liu Z, Wang Y, Luo H, Yang C, Shen H Aging (Albany NY). 2024; 16(5):4699-4722.

PMID: 38460946 PMC: 10968700. DOI: 10.18632/aging.205626.

References

Cao L, Cheng H, Jiang Q, Li H, Wu Z . APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging (Albany NY). 2020; 12(5):4573-4591. PMC: 7093175. DOI: 10.18632/aging.102913. View

Feng Y, Li Y, Li L, Wang X, Chen Z . Identification of specific modules and significant genes associated with colon cancer by weighted gene co‑expression network analysis. Mol Med Rep. 2019; 20(1):693-700. DOI: 10.3892/mmr.2019.10295. View

Meng J, Liu Y, Guan S, Fan S, Zhou J, Zhang M . The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer. Cancer Med. 2019; 8(11):5202-5213. PMC: 6718526. DOI: 10.1002/cam4.2433. View

Dettmer U, Kuhn P, Abou-Ajram C, Lichtenthaler S, Kruger M, Kremmer E . Transmembrane protein 147 (TMEM147) is a novel component of the Nicalin-NOMO protein complex. J Biol Chem. 2010; 285(34):26174-81. PMC: 2924024. DOI: 10.1074/jbc.M110.132548. View

Zhang B, Zhang Y, Zou X, Chan A, Zhang R, Lee T . The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. J Pathol. 2017; 243(4):418-430. PMC: 5725705. DOI: 10.1002/path.4976. View

Wang P, Zhang X, Sun N, Zhao Z, He J . Comprehensive Analysis of the Tumor Microenvironment in Cutaneous Melanoma associated with Immune Infiltration. J Cancer. 2020; 11(13):3858-3870. PMC: 7171484. DOI: 10.7150/jca.44413. View

Zhu S, Chen C, Hao Y . LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146. J Mol Histol. 2021; 52(3):479-490. DOI: 10.1007/s10735-020-09942-0. View

Christodoulou A, Maimaris G, Makrigiorgi A, Charidemou E, Luchtenborg C, Ververis A . TMEM147 interacts with lamin B receptor, regulates its localization and levels, and affects cholesterol homeostasis. J Cell Sci. 2020; 133(16). DOI: 10.1242/jcs.245357. View

Ren M, Qiu S, Venglat P, Xiang D, Feng L, Selvaraj G . Target of rapamycin regulates development and ribosomal RNA expression through kinase domain in Arabidopsis. Plant Physiol. 2011; 155(3):1367-82. PMC: 3046592. DOI: 10.1104/pp.110.169045. View

10.

Du R, Shen W, Liu Y, Gao W, Zhou W, Li J . TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness. Signal Transduct Target Ther. 2019; 4:60. PMC: 6908606. DOI: 10.1038/s41392-019-0098-x. View

11.

Creamer K, Larsen E, Lawrence J . ZNF146/OZF and ZNF507 target LINE-1 sequences. G3 (Bethesda). 2022; 12(3). PMC: 8896011. DOI: 10.1093/g3journal/jkac002. View

12.

Jiang L, Dong R, Ying M, He Q, Cao J, Yang B . Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics. Br J Pharmacol. 2018; 175(23):4285-4294. PMC: 6240126. DOI: 10.1111/bph.14511. View

13.

Zhou G, Soufan O, Ewald J, Hancock R, Basu N, Xia J . NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019; 47(W1):W234-W241. PMC: 6602507. DOI: 10.1093/nar/gkz240. View

14.

Maimaris G, Christodoulou A, Santama N, Lederer C . Regulation of ER Composition and Extent, and Putative Action in Protein Networks by ER/NE Protein TMEM147. Int J Mol Sci. 2021; 22(19). PMC: 8508377. DOI: 10.3390/ijms221910231. View

15.

Schmit K, Michiels C . TMEM Proteins in Cancer: A Review. Front Pharmacol. 2018; 9:1345. PMC: 6291505. DOI: 10.3389/fphar.2018.01345. View

16.

Li Q, Huang Z, Chen Y, Yao H, Ke Z, He X . Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining. J Cancer. 2020; 11(9):2453-2464. PMC: 7066007. DOI: 10.7150/jca.38747. View

17.

Iwagami Y, Huang C, Olsen M, Thomas J, Jang G, Kim M . Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology. 2015; 63(4):1213-26. PMC: 4805474. DOI: 10.1002/hep.28411. View

18.

Ma Y, Cong X, Zhang Y, Yin X, Zhu Z, Xue Y . CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis. Cancer Cell Int. 2020; 20:81. PMC: 7071687. DOI: 10.1186/s12935-020-1122-5. View

19.

Zhu W, Li H, Yu Y, Chen J, Chen X, Ren F . Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients. Cancer Manag Res. 2018; 10:5735-5745. PMC: 6245378. DOI: 10.2147/CMAR.S182183. View

20.

Chen L, Karisma V, Liu H, Zhong L . MicroRNA-300: A Transcellular Mediator in Exosome Regulates Melanoma Progression. Front Oncol. 2019; 9:1005. PMC: 6803498. DOI: 10.3389/fonc.2019.01005. View